Skip to main content
ASPI
NASDAQ Industrial Applications And Services

ASP Isotopes' QLE Subsidiary Inks Non-Binding MOU with Major U.S. Energy Firm for Nuclear Fuel Supply

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
7
Price
$5.1
Mkt Cap
$639.313M
52W Low
$3.71
52W High
$14.49
52W Position info
37% above low
Off High info
65% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ASPI sits 37% above its 52-week low of $3.71.

Summary

ASP Isotopes' subsidiary, Quantum Leap Energy, signed a non-binding MOU with a major U.S. energy company to evaluate support for advancing the domestic enriched uranium fuel supply chain.


Key Events · M&A and Partnerships · ASPI

  • Non-Binding MOU Signed

    Quantum Leap Energy (QLE), a wholly-owned subsidiary of ASP Isotopes Inc., entered into a non-binding Memorandum of Understanding with a large publicly traded U.S. energy company that operates nuclear power stations.

  • Focus on Domestic Nuclear Fuel Supply

    The MOU aims to evaluate options for the U.S. energy company to support QLE's plans to establish advanced nuclear fuel cycle facilities in the United States, focusing on High Assay Low Enriched Uranium (HALEU) and Low Enriched Uranium Plus (LEU+) production, and uranium conversion services.

  • Potential Financial Support Outlined

    The agreement outlines potential terms for providing financial support to QLE through definitive agreements for the supply of enriched uranium, addressing a critical need for strengthening America's domestic nuclear fuel supply chain.


Analysis · ASPI · Industrial Applications And Services

This non-binding Memorandum of Understanding (MOU) is a significant step for ASP Isotopes' subsidiary, Quantum Leap Energy (QLE), as it signals interest from a large U.S. energy company in supporting the domestic advanced nuclear fuel supply chain. While non-binding, the MOU validates QLE's strategic direction and its efforts to address the critical need for High Assay Low Enriched Uranium (HALEU) and Low Enriched Uranium Plus (LEU+) in the United States, especially with the impending ban on Russian uranium imports. This development could lead to future definitive agreements for financial support and enriched uranium supply, strengthening QLE's position in a vital sector.

How filings like this one have moved

In the 30 days to Sep 14, 2026, 29.9% of the 1594 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ASPI was trading at $5.10 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $639.3M. The 52-week trading range was $3.71 to $14.49. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ASPI - Latest Insights

ASPI
Sep 09, 2026, 6:33 AM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $4.22
Real-time Price: $3.33 info
Change: -$0.890 (-21%) info
Market Cap: $507.454M info
ASPI
Aug 20, 2026, 8:22 PM EDT
Filing Type: 425
Importance Score:
8
Price at Filing: $4.00
Real-time Price: $3.33 info
Change: -$0.670 (-17%) info
Market Cap: $507.454M info
ASPI
Aug 20, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.90
Real-time Price: $3.33 info
Change: -$0.570 (-15%) info
Market Cap: $507.454M info
ASPI
Aug 20, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $3.33 info
Change: -$0.770 (-19%) info
Market Cap: $507.454M info
ASPI
Aug 14, 2026, 5:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.14
Real-time Price: $3.33 info
Change: -$0.810 (-20%) info
Market Cap: $507.454M info